drugset / Trial / NCT06311942
Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Vessels that encapsulate tumor clusters (VETC) is an invasive metastatic factor in HCC independent of the epithelial mesenchyme transition (EMT), and VETC-positive patients have a higher rate of postoperative recurrence. What can be done to improve the surgical prognosis of this group of patients needs to be continuously explored.
Timeline
- Start
- 2024-04-01
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | — |
| Subject | fluorouracil | Small molecule | — | — |
| Background | Lenvatinib | Small molecule | — | Oral |
| Background | Leucovorin | Small molecule | — | — |